News

Xyntek is involved in providing real-time automated IT systems and microprocessor based industrial automation solutions to the life sciences industries. Xyntek president and CEO Mac Hashemian said the

The service will aid in the development of molecular tests for trial enrichment and companion diagnostic development, focussing on targeted re-sequencing. Almac Diagnostics business unit president and managing

The anti-tumor technology consists of methods for isolation and propagation of the primary human cells, gene profiles obtained from the cells identifying candidate micro RNAs and growth factor

Upon closing of the acquisition, Biochrom’s operations will be maintained in Berlin while its activities will be part of Merck Millipore’s Process Solutions business unit. The acquisition, which

Gevokizumab (XOMA 052) is a potent monoclonal antibody that strongly binds to interleukin-1 beta (IL-1 beta) and possesses allosteric modulating properties capable of treating patients suffering from a

West chairman and chief executive officer Donald Morel Jr, commenting on the commencement of first facility in India, said the company is experiencing a rapid growth and expanding

The new Beijing facility is expected to enhance PRA local project teams’ ability in meeting the growing demand for its clinical drug development programs and also to collocate

Heplisav is indicated for immunization against infection caused by all known subtypes of hepatitis B virus in people aged 18 through 70 years of age and in patients

As part of the new agreement, Ipsen will gain commercial rights in key territories, while Inspiration will develop OBI-1 and IB1001 across the world. Under the negotiation, Ipsen